Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US2016168609A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016168609-A1 |
| Application number | US-201514941492-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 13, 2015 |
| Priority date | Apr 4, 2011 |
| Publication date | Jun 16, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides compositions and methods related to the degradation of cellulose and cellulose-containing materials. CDH-heme domain polypeptides and GH61 polypeptides and related polynucleotides and compositions are provided herein. Additionally, methods related to CDH-heme domain polypeptides, GH61 polypeptides, and related polynucleotides and compositions, are provided herein
Opening claim text (preview).
1 - 18 . (canceled) 19 . A method of degrading cellulose, the method comprising contacting the cellulose with: one or more cellulases, a recombinant GH61 polypeptide; and a recombinant CDH-heme domain polypeptide comprising a cellulose binding module (CBM), wherein the contact occurs in a reaction mixture, and wherein the contact occurs for a time sufficient to yield degraded cellulose. 20 - 27 : (canceled) 28 . The method of claim 19 , wherein at least 50% of the GH61 polypeptides are bound to a copper atom. 29 . The method of claim 19 , wherein at least 90% of the GH61 polypeptides are bound to a copper atom. 30 - 31 : (canceled) 32 . The method of claim 19 , wherein the recombinant GH61 polypeptide comprises the amino acid sequence of SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 90. 33 - 37 : (canceled) 38 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises the amino acid sequence of SEQ ID NO: 32 or SEQ ID NO: 46. 39 . The method of claim 19 , wherein the CDH-heme domain comprises the amino acid sequence selected from the group consisting of SEQ ID NO: 70, SEQ ID NO: 76, SEQ ID NO: 80, and SEQ ID NO: 86, and wherein the CBM comprises the amino acid sequence of SEQ ID NO: 74 or SEQ ID NO: 84. 40 . The method of claim 19 , wherein the method further comprises having a concentration of between 0.1-500 μM copper in the reaction mixture. 41 . The method of claim 40 , wherein the concentration of copper in the reaction mixture is 1-50 μM. 42 . The method of claim 19 , wherein the recombinant GH61 polypeptide comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 90. 43 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 32 or SEQ ID NO: 46. 44 . The method of claim 19 , wherein the CDH-heme domain comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence selected from the group consisting of SEQ ID NO: 70, SEQ ID NO: 76, SEQ ID NO: 80, and SEQ ID NO: 86, and wherein the CBM comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 74 or SEQ ID NO: 84. 45 . The method of claim 19 , wherein the recombinant GH61 polypeptide comprises the motif H-X (4-8) -Q-X-Y. 46 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises a first domain and a second domain, wherein the first domain comprises a CDH-heme domain and the second domain comprises a CBM, and wherein the polypeptide does not contain a dehydrogenase domain. 47 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises a first domain, a second domain, and a third domain, wherein the first domain comprises a CDH-heme domain, the second domain comprises a CBM, and the third domain comprises a dehydrogenase domain.
acting on CH-OH groups as donors (1.1) · CPC title
produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title
Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title
Treatment of cellulose-containing material with microorganisms or enzymes · CPC title
Fusion polypeptide · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.